MSD India, established in 2010, operates within the manufacturing sector, specifically focusing on pharmaceuticals and biotechnology. The company employs between 201 and 500 individuals and has reported significant revenue, underscoring its role in the biopharmaceutical industry. MSD India is committed to advancing health solutions, particularly through its Access to Health strategy, which aims to improve healthcare access for underserved populations in low- and middle-income countries, as well as in high-income countries. The company’s philanthropic initiatives are encapsulated in its Global Impact Investing and Giving (GIIG) platform, which invests in community health programs designed to address local healthcare needs. One of its notable initiatives is the Solutions for Healthy Communities Grant Program, which seeks to catalyze innovative health solutions through local stakeholder engagement. This program reflects MSD's dedication to social impact and sustainability, aiming to enhance the health and wellbeing of communities where it operates. Through these efforts, MSD India demonstrates its commitment to being a research-intensive biopharmaceutical company focused on delivering innovative healthcare solutions.